scholarly article | Q13442814 |
P356 | DOI | 10.1128/JVI.02652-15 |
P8608 | Fatcat ID | release_7xbzlu6xhzcaphpw7gnveir5mi |
P932 | PMC publication ID | 4810649 |
P698 | PubMed publication ID | 26719252 |
P50 | author | Andrew B Ward | Q90160109 |
Richard T. Wyatt | Q96247131 | ||
P2093 | author name string | Natalia de Val | |
Javier Guenaga | |||
Viktoriya Dubrovskaya | |||
Shailendra K Sharma | |||
Barbara Carrette | |||
P2860 | cites work | Codon usage limitation in the expression of HIV-1 envelope glycoprotein | Q24498729 |
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 | Q27643185 | ||
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env | Q27644383 | ||
Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy | Q27680442 | ||
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer | Q27680496 | ||
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer | Q27680497 | ||
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers | Q27683553 | ||
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
A new generation of the IMAGIC image processing system | Q28131751 | ||
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies | Q28299280 | ||
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers | Q28647225 | ||
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
Appion: an integrated, database-driven pipeline to facilitate EM image processing | Q29614288 | ||
Automated molecular microscopy: the new Leginon system | Q29614290 | ||
Broad neutralization coverage of HIV by multiple highly potent antibodies | Q29615361 | ||
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 | Q29619511 | ||
A clustering approach to multireference alignment of single-particle projections in electron microscopy | Q33548939 | ||
Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution | Q33804811 | ||
Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins | Q33806056 | ||
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. | Q33835295 | ||
Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers | Q33836042 | ||
Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus | Q33930424 | ||
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins | Q34332728 | ||
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. | Q34361680 | ||
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex | Q34709433 | ||
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers | Q34743297 | ||
Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure | Q34831341 | ||
Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin | Q34999293 | ||
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene | Q35110976 | ||
Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 | ||
Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties | Q35540033 | ||
Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env. | Q35641498 | ||
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens | Q36102994 | ||
HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins | Q36276274 | ||
Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. | Q36633402 | ||
Broad HIV-1 neutralization mediated by CD4-binding site antibodies | Q36977635 | ||
Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein | Q37123584 | ||
DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy | Q37401395 | ||
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein | Q37742876 | ||
Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate | Q39484956 | ||
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure | Q39588870 | ||
Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design | Q41042362 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2806-2817 | |
P577 | publication date | 2015-12-30 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers | |
P478 | volume | 90 |
Q54237723 | A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers |
Q40463159 | An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes. |
Q59351009 | An HIV-1 broadly neutralizing antibody from a clade C infected pediatric elite neutralizer potently neutralizes the contemporaneous and autologous evolving viruses |
Q36267348 | Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs |
Q61795909 | Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide |
Q40108631 | Characterization of a stable HIV-1 B/C recombinant, soluble and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes |
Q91427933 | Characterization of native-like HIV-1 gp140 glycoprotein expressed in insect cells |
Q95627977 | Controlling the SARS-CoV-2 Spike Glycoprotein Conformation |
Q97652986 | Controlling the SARS-CoV-2 spike glycoprotein conformation |
Q37695592 | Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers |
Q37482035 | Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer |
Q92932198 | Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements |
Q36194234 | Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth |
Q92828111 | Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function |
Q33830824 | Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches |
Q90182956 | Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle |
Q37300461 | Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates |
Q88985874 | Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 |
Q37649155 | Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein. |
Q38992740 | Evolution of B cell analysis and Env trimer redesign |
Q36003168 | Evolution of coreceptor utilization to escape CCR5 antagonist therapy. |
Q41924154 | Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex |
Q47096121 | Glutaraldehyde Cross-linking of HIV-1 Env Trimers Skews the Antibody Subclass Response in Mice |
Q33711154 | Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein |
Q95323134 | Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help |
Q46454115 | HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage |
Q40073016 | HIV-1 Cross-reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Non-human Primate |
Q39365785 | HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike |
Q89746983 | HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice |
Q59339672 | HIV-1 vaccine design through minimizing envelope metastability |
Q59360730 | Harnessing post-translational modifications for next-generation HIV immunogens |
Q40061438 | Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer |
Q46272894 | High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers |
Q38708708 | Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. |
Q47364595 | Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization |
Q37633417 | Native-like Env trimers as a platform for HIV-1 vaccine design |
Q91691714 | Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization |
Q40198048 | Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach |
Q37549777 | Progress toward active or passive HIV-1 vaccination |
Q53081267 | Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity |
Q38712684 | Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein |
Q47313525 | Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers |
Q30490942 | Stabilized HIV-1 envelope glycoprotein trimers for vaccine use. |
Q57091049 | Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies |
Q98384046 | Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens |
Q37376640 | Structural basis for membrane anchoring of HIV-1 envelope spike |
Q52338073 | Structure and Immune Recognition of the HIV Glycan Shield |
Q92382176 | Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence |
Q90675709 | Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage |
Q46631754 | Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. |
Q40043429 | Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response |
Q39108730 | Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem |
Q39108789 | The HIV-1 envelope glycoprotein structure: nailing down a moving target |
Q28553360 | Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies |
Q37060986 | Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. |
Search more.